E2112 – A Randomized Phase III Trial of Endocrine Therapy plus Entinostat or Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer

Physician and Research Staff Educational Materials:

These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.

  • Pocket Reference Card: trial schema, study objectives, and eligibility requirements on a pocket-sized card for easy reference when consulting with patients in the office or on rounds.
  • Study Summary for Physicians: schema, study objectives, eligibility criteria, and other key information about the study.
  • Physician Fact Sheet: schema, study objectives, eligibility criteria, and other key information about the study.

Dr. ConnollyE2112 Webinar: Dr. Connolly hosted a webinar in December 2014 for investigators and other research personnel interested in enrolling patients to this trial. Dr. Connolly provided an overview of the study and answered questions from participants at the conclusion of her presentation. (view Dr. Connolly’s bio). The webinar slides are posted on ECOG.org and CTSU.org (passwords required). Other inquiries about this webinar may be directed to the ECOG-ACRIN Clinical Education and Awareness Team via email.

 

Patient Educational Materials:

  • Study Summary for Patients: study objectives, eligibility criteria, and a simplified schema in lay language to provide a more visual description of the trial to patients.

Participating sites should note that the Central Institutional Review Board (CIRB) has approved these documents. For sites utilizing local IRBs, please submit this in accordance with your local IRB policies prior to use.

Information and Assistance from the National Cancer Institute:

  • Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.

Additional Information on ClinicalTrials.gov: Displayed below is an interactive view of the study record as it appears in the government registry. If you are experiencing technical difficulties with this view, visit clinicaltrials.gov and search for record NCT02115282.